水素豊富溶液：放射線防護剤としての有効性・安全性に関する仮説
Ionizing radiation causes tissue damage primarily through the generation of reactive oxygen species (ROS). Established radioprotective compounds such as amifostine act by scavenging these radicals. Emerging evidence indicates that molecular hydrogen selectively neutralizes hydroxyl radicals and peroxynitrite, conferring protection against ischemia-reperfusion injury and stroke in the brain and intestine. Based on this antioxidant selectivity, the authors propose that hydrogen could serve as a novel and effective radioprotective agent. Because H2 gas carries explosion risk, hydrogen-rich solution—physiological saline saturated with molecular hydrogen—is presented as a safer alternative delivery vehicle. This hypothesis paper outlines the rationale for investigating hydrogen-rich saline in the context of radiation protection.
Molecular hydrogen is proposed to selectively scavenge hydroxyl radicals and peroxynitrite generated by ionizing radiation, thereby reducing oxidative tissue damage without broadly suppressing physiological ROS signaling.
Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).
See also:
https://h2-papers.org/en/papers/21275114